IT1187751B - Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute - Google Patents

Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Info

Publication number
IT1187751B
IT1187751B IT22494/85A IT2249485A IT1187751B IT 1187751 B IT1187751 B IT 1187751B IT 22494/85 A IT22494/85 A IT 22494/85A IT 2249485 A IT2249485 A IT 2249485A IT 1187751 B IT1187751 B IT 1187751B
Authority
IT
Italy
Prior art keywords
formulations
polyethylene glycol
active substance
nifedipine
solution
Prior art date
Application number
IT22494/85A
Other languages
English (en)
Other versions
IT8522494A0 (it
Inventor
Piergiorgio Rossi
Massimo Calanchi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Publication of IT8522494A0 publication Critical patent/IT8522494A0/it
Priority to IT22494/85A priority Critical patent/IT1187751B/it
Priority to DE8686201704T priority patent/DE3680989D1/de
Priority to EP86201704A priority patent/EP0220760B1/en
Priority to ES198686201704T priority patent/ES2040209T3/es
Priority to AT86201704T priority patent/ATE66367T1/de
Priority to NZ217841A priority patent/NZ217841A/en
Priority to DK481186A priority patent/DK168691B1/da
Priority to PT83522A priority patent/PT83522B/pt
Priority to NO864060A priority patent/NO172168C/no
Priority to AU63832/86A priority patent/AU590622B2/en
Priority to ZA867767A priority patent/ZA867767B/xx
Priority to JP61242180A priority patent/JPH0811731B2/ja
Priority to CA000520378A priority patent/CA1280976C/en
Priority to US06/918,382 priority patent/US4880623A/en
Priority to FI864151A priority patent/FI87424C/fi
Priority to KR1019860008647A priority patent/KR940006320B1/ko
Application granted granted Critical
Publication of IT1187751B publication Critical patent/IT1187751B/it
Priority to GR91401773T priority patent/GR3003150T3/el
Priority to HK12595A priority patent/HK12595A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
IT22494/85A 1985-10-15 1985-10-15 Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute IT1187751B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT22494/85A IT1187751B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
DE8686201704T DE3680989D1 (de) 1985-10-15 1986-10-02 Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen.
EP86201704A EP0220760B1 (en) 1985-10-15 1986-10-02 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained
ES198686201704T ES2040209T3 (es) 1985-10-15 1986-10-02 Procedimiento de preparacion de formulaciones de nifedipina solida de alta disponibilidad biologica y con efecto sostenido, y las formulaciones obtenidas.
AT86201704T ATE66367T1 (de) 1985-10-15 1986-10-02 Verfahren zur herstellung von festen nifedipinzusammensetzungen mit verzoegerter abgabe und so erhaltene zusammensetzungen.
NZ217841A NZ217841A (en) 1985-10-15 1986-10-07 Solid pharmaceutical formulations containing nifedipine or a derivative thereof present on very fine particles of carrier with very high total specific surface
DK481186A DK168691B1 (da) 1985-10-15 1986-10-08 Fast farmaceutisk præparat indeholdende nifedipin eller derivater deraf og fremgangsmåde til fremstilling af præparatet
PT83522A PT83522B (pt) 1985-10-15 1986-10-10 Processo para a preparacao de formulacoes de nifedipina solidas de elevada eficacia biologica e com efeito prolongado
NO864060A NO172168C (no) 1985-10-15 1986-10-13 Fremgangsmaate for fremstilling av faste nifedipinpreparater med hoey biotilgjengelighet og med forlenget virkning
AU63832/86A AU590622B2 (en) 1985-10-15 1986-10-13 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained
ZA867767A ZA867767B (en) 1985-10-15 1986-10-14 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect,and formulations thus obtained
JP61242180A JPH0811731B2 (ja) 1985-10-15 1986-10-14 固形ニフエジピン製剤の製造方法及びそのようにして得られた製剤
CA000520378A CA1280976C (en) 1985-10-15 1986-10-14 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thusobtained
US06/918,382 US4880623A (en) 1985-10-15 1986-10-14 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained
FI864151A FI87424C (fi) 1985-10-15 1986-10-14 Foerfarande foer framstaellning av fasta nifedipinpreparat, som biologiskt laett kan tillgodogoeras och som har en foerdroejd effekt
KR1019860008647A KR940006320B1 (ko) 1985-10-15 1986-10-15 고 생체이용율 및 서방성 효과를 갖는 니페디핀의 고형 제제의 제조방법
GR91401773T GR3003150T3 (en) 1985-10-15 1991-11-19 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained
HK12595A HK12595A (en) 1985-10-15 1995-01-26 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22494/85A IT1187751B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Publications (2)

Publication Number Publication Date
IT8522494A0 IT8522494A0 (it) 1985-10-15
IT1187751B true IT1187751B (it) 1987-12-23

Family

ID=11197023

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22494/85A IT1187751B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute

Country Status (18)

Country Link
US (1) US4880623A (it)
EP (1) EP0220760B1 (it)
JP (1) JPH0811731B2 (it)
KR (1) KR940006320B1 (it)
AT (1) ATE66367T1 (it)
AU (1) AU590622B2 (it)
CA (1) CA1280976C (it)
DE (1) DE3680989D1 (it)
DK (1) DK168691B1 (it)
ES (1) ES2040209T3 (it)
FI (1) FI87424C (it)
GR (1) GR3003150T3 (it)
HK (1) HK12595A (it)
IT (1) IT1187751B (it)
NO (1) NO172168C (it)
NZ (1) NZ217841A (it)
PT (1) PT83522B (it)
ZA (1) ZA867767B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US5215752A (en) * 1988-03-17 1993-06-01 Vectorpharma International S.P.A. Pharmaceutical tablets and capsule granulates of scleroglucan and active substance
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
DK0557244T3 (da) * 1992-02-17 1996-04-01 Siegfried Ag Pharma Dosisformer med forlænget afgivelse af aktivt stof
IL104192A (en) * 1992-02-17 1998-01-04 Siegfried Ag Pharma Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
CA2352211C (en) * 1999-09-30 2009-03-24 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
CA2395331C (en) 1999-12-23 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
IL134701A0 (en) 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
WO2003033462A2 (en) * 2001-10-15 2003-04-24 The Regents Of The University Of Michigan Systems and methods for the generation of crystalline polymorphs
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
CA2511992A1 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
WO2004087102A2 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
CA2644069A1 (en) * 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN102014918A (zh) * 2007-04-20 2011-04-13 太阳医药工业有限公司 由微量沉淀产生的药学组合物
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO98434A (it) * 1959-04-30
US3920809A (en) * 1973-11-05 1975-11-18 Lilly Co Eli Dibenzo(b,d)pyranone dispersions
US3988439A (en) * 1973-11-05 1976-10-26 Eli Lilly And Company Dibenzo[b,d]pyranone dispersions
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4311694A (en) * 1979-12-31 1982-01-19 American Cyanamid Company Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ATE66367T1 (de) 1991-09-15
DK168691B1 (da) 1994-05-24
KR870003779A (ko) 1987-05-04
NO172168C (no) 1993-06-16
HK12595A (en) 1995-02-03
DK481186A (da) 1987-04-16
GR3003150T3 (en) 1993-02-17
US4880623A (en) 1989-11-14
AU6383286A (en) 1987-04-16
EP0220760A2 (en) 1987-05-06
PT83522A (en) 1986-11-01
NZ217841A (en) 1990-01-29
DK481186D0 (da) 1986-10-08
FI87424C (fi) 1993-01-11
IT8522494A0 (it) 1985-10-15
ZA867767B (en) 1987-06-24
NO172168B (no) 1993-03-08
PT83522B (pt) 1988-11-30
KR940006320B1 (ko) 1994-07-16
DE3680989D1 (de) 1991-09-26
FI864151A0 (fi) 1986-10-14
NO864060D0 (no) 1986-10-13
EP0220760B1 (en) 1991-08-21
EP0220760A3 (en) 1987-09-23
JPS62167727A (ja) 1987-07-24
JPH0811731B2 (ja) 1996-02-07
CA1280976C (en) 1991-03-05
FI87424B (fi) 1992-09-30
ES2040209T3 (es) 1993-10-16
FI864151A (fi) 1987-04-16
NO864060L (no) 1987-04-21
AU590622B2 (en) 1989-11-09

Similar Documents

Publication Publication Date Title
IT1187751B (it) Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
CA1269328A (en) Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same
JP2793280B2 (ja) モルヒネ含有組成物
CA1329543C (en) Human growth hormone formulation
EP1175205B1 (en) Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
CA1294963C (en) Benzoyl urea compound
ATE62408T1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
ES2077897T3 (es) Preparados farmaceuticos secos de dosis bajas.
NO842290L (no) Fremgangsmaate for fremstilling av preparater inneholdende oralt antidiabetisk aktive stoffer
KR850008279A (ko) 경피투여용 약제의 제조방법
JPS6322527A (ja) 担体としてガラクチト−ルを含む医薬組成物
JPS5649314A (en) Lasting pharmaceutical composition having prolonged action and its preparation
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
DE69233678D1 (de) Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren
EP0223033B1 (de) Verfahren zum gleichzeitigen Trocknen und Granulieren von Extraktstoffen aus enteiweisstem Kälberblut, nach diesem Verfahren erhaltenes Granulat und dessen Verwendung zur Herstellung von pharmazeutischen Präparaten
JPH0135807B2 (it)
Wisudyaningsih et al. IAI SPECIAL EDITION: Effect of gelling agent and penetration enhancer on the release rate of ibuprofen-PEG 6000 solid dispersion from gel preparations
KR0185294B1 (ko) 투명액상 이부프로펜 조성물 및 이를 함유하는 연질캅셀제
EP3124016B1 (en) Antipsoriatic emulsion composition comprising cefazolin
JPS55129220A (en) Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability
JP2750130B2 (ja) 経口投与用組成物
HU212498B (en) Process for producing water-soluble pharmaceutical compositions, containing sulfachlorpyridazin-sodium and trimethoprim